analyzeportfolio
NYSE · Materials

ALBEMARLE CORP (ALB)

As-reported financials and SEC filings for ALBEMARLE CORP. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About ALBEMARLE CORP

Albemarle Corporation produces and supplies specialty chemicals with a focus on lithium compounds, bromine-based products, and refining catalysts. Its main business segments include Energy Storage, which manufactures lithium compounds for batteries and other applications; Specialties, which provides bromine and lithium specialty chemicals for industries such as automotive, electronics, and pharmaceuticals; and Ketjen, which offers catalysts used in oil refining and chemical manufacturing. Albemarle serves customers worldwide across various industries including automotive, energy, electronics, and healthcare.

Snapshot

Revenue
$5.14B
Revenue growth (YoY)
-4.4%
Net income
$-510.6M
Diluted EPS
$-5.76
Gross margin
13.0%
Operating margin
-7.1%
Net margin
-9.9%
FCF margin
13.5%
ROE
-5.2%
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$14.90B
Long-term debt / equity
0.32×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Albemarle

  • Revenue fell 4.4% to $5.1B in FY2025, after a 44.1% decline the year before.
  • Operating margin is now a 7.1% loss in FY2025, from 24.0% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $1.7B, up 31.1% from Q2 FY2025.
  • Free cash flow was $692M in FY2025, 13.5% of revenue.
  • Net loss narrowed to $511M in FY2025, from $1.2B in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Albemarle’s fundamentals sit among the 241 Materials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin13.0%
16th percentile of 191
Operating margin-7.1%
22nd percentile of 189
Net margin-9.9%
22nd percentile of 221
FCF margin13.5%
87th percentile of 205
Revenue growth (YoY)-4.4%
27th percentile of 236
ROE-5.2%
34th percentile of 216
Long-term debt / equity0.32×
28th percentile of 165
Short interest5.23d
63rd percentile of 237

Albemarle’s FCF margin of 13.5% ranks in the 87th percentile of the 205 Materials companies reporting it.

No reported insider transactions (codes P/S) in the last 90 days. For context, about 14% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+6 quant / multi-strat
Initiated / added
3
0 new, 3 added
Reduced / exited
5
5 trimmed, 0 exited
Combined position
$606.7M
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$197.2M1.5MReduced
AQR Capital ManagementquantQ2 2026$154.6M1.2MReduced
Citadel AdvisorsquantQ2 2026$118.2M875.1KAdded
Renaissance TechnologiesquantQ2 2026$61.6M456.1KReduced
Gotham Asset ManagementQ2 2026$28.6M211.5KAdded
D. E. ShawquantQ2 2026$17.7M131.2KReduced
Bridgewater AssociatesQ2 2026$15.7M116.3KAdded
Millennium ManagementquantQ2 2026$13.1M96.9KReduced

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
0
Reported activity
Quiet
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-05-15
filed 2026-05-19
Masters J KentChairman & CEOSell11.9K$183.87$2.2M
2026-05-15
filed 2026-05-19
Masters J KentChairman & CEOSell3.8K$183.12$701K
2026-05-15
filed 2026-05-19
Masters J KentChairman & CEOSell700$184.52$129K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
9.6M
settled 2026-08-31
Change vs prior
-5.9%
vs previous settlement
Days to cover
5.23
at avg daily volume
Avg daily volume
1.8M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-319.6M-5.9%5.23
2026-08-1410.2M-8.5%4.22
2026-07-3111.2M+4.3%4.73
2026-07-1510.7M-2.4%5.75
2026-06-3011.0M+0.2%3.77
2026-06-1511.0M+2.0%4.61
2026-05-2910.8M+0.4%5.41
2026-05-1510.7M+4.1%4.75

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$5.14B$5.38B$9.62B$7.32B$3.33B
Gross profit$668.7M$62.5M$1.19B$3.07B$998.0M
Operating income$-367.1M$-1.78B$251.9M$2.47B$798.4M
Net income$-510.6M$-1.18B$1.57B$2.69B$123.7M
Diluted EPS$-5.76$-11.20$13.36$22.84$1.06

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$1.62B$1.19B$889.9M$1.50B$439.3M
Current assets$4.01B$3.84B$5.22B$5.19B$1.99B
Total assets$16.37B$16.61B$18.27B$15.46B$10.97B
Current liabilities$1.80B$1.97B$3.56B$2.74B$1.87B
Long-term debt$3.12B$3.12B$3.54B$3.21B$2.00B
Total liabilities$6.59B$6.41B$8.61B$7.27B$5.17B
Total equity$9.78B$10.20B$9.67B$8.19B$5.81B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$1.28B$687.9M$1.33B$1.91B$344.3M
Capital expenditure$589.8M$1.68B$2.15B$1.26B$953.7M
Free cash flow$692.5M$-992.7M$-828.0M$646.2M$-609.4M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$1.74B31.1%$480.0M$3.52
Q1 FY2026$1.43B32.7%$319.1M$2.34
Q4 FY2025$1.43B15.9%$-414.2M$-3.52
Q3 FY2025$1.31B-3.5%$-160.7M$-1.72
Q2 FY2025$1.33B-7.0%$22.9M
Q1 FY2025$1.08B-20.9%$41.3M$0.00
Q4 FY2024$1.23B-47.7%$75.3M$0.64
Q3 FY2024$1.35B-41.4%$-1.07B$-9.45

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorMaterials
SIC industryPlastic Materials, Synth Resins & Nonvulcan Elastomers
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2014
SEC CIK915913

Selected SEC filings

10-K/A2026-03-31
View on EDGAR →
10-Q2026-08-05
View on EDGAR →
10-Q2026-05-06
View on EDGAR →
8-K2026-09-03
View on EDGAR →
8-K2026-08-21
View on EDGAR →
8-K2026-08-05
View on EDGAR →
8-K2026-07-23
View on EDGAR →

Largest Materials peers

All Materials companies →

Monitor ALB

Get an alert when Albemarle files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor ALB free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.